About the Company
We do not have any company description for Cancer Genetics Inc. at the moment.
Please visit http://www.cancergenetics.com for more information about the company.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $CGIX News
Peninsula biopharma wins 1st FDA approval for drug targeting type of brain cancer in kids
Branded as Ojemda, the newly approved drug targets a type of childhood brain cancer that has returned or isn't responding to ...
How Olema Oncology moved from layoffs to pivotal cancer drug studies
A drug developer that cut a quarter of its workforce last year is now hiring as it plans to push a second drug into clinical ...
Myriad Genetics (MYGN) Announces Favorable Research Results
Myriad Genetics, Inc. MYGN recently announced results from a multi-year, real-world study that indicated those with major depressive disorder had reduced healthcare utilization after taking the ...
Dr. Oz discusses how to reduce your cancer risk
It seems like lots of my contemporaries are getting cancer. I’m 48 and want to know how I can dodge the bullet.
FDA Advisory Panel Review of Guardant Health’s Shield™ Blood Test to Screen for Colorectal Cancer to Be Held on May 23
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the Molecular and Clinical Genetics ...
Unlocking the Genetic Codes of Alcohol Consumption
Exploration of 3 million records uncovers connections between gene variants governing alcohol use and many ...
Lab, pharma company partner to push biomarker testing to determine cancer treatment approach
Breast cancer is currently the world’s mostly commonly diagnosed cancer. It is a form of cancer that originates from breast ...
Atossa Therapeutics Poised for Growth with Promising Breast Cancer Treatment
Analyst Jason McCarthy from Maxim Group maintained a Buy rating on Atossa Therapeutics (ATOS – Research Report) and keeping the price ...
Detoxicare, AstraZeneca collaborate on groundbreaking breast cancer testing
Detoxicare Molecular Diagnostics Laboratory, a subsidiary of Detoxicare Philippines Inc., recently inked a partnership deal with global biopharmaceutical company AstraZeneca to spearhead ...
Insider Sell: CFO Michael Brophy Sells Shares of Natera Inc (NTRA)
Michael Brophy, the Chief Financial Officer of Natera Inc (NASDAQ:NTRA), has sold 1,523 shares of the company on April 23, ...
Loading the latest forecasts...